Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression

OBJECTIVE: To determine the feasibility of pharmacologic beta-adrenergic blockade in women with newly diagnosed stage II-IV epithelial ovarian cancer (EOC) throughout primary treatment. METHODS: Patients initiated propranolol prior to beginning chemotherapy or surgery. Feasibility was assessed as pr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gynecol Oncol
Egile Nagusiak: Ramondetta, Lois M., Hu, Wei, Thaker, Premal H., Urbauer, Diana L., Chisholm, Gary B., Westin, Shannon N., Sun, Yunjie, Ramirez, Pedro T., Fleming, Nicole, Sahai, Sunil K., Nick, Alpa M., Arevalo, Jesusa M. G., Dizon, Thomas, Coleman, Robert L., Cole, Steve W., Sood, Anil K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6867685/
https://ncbi.nlm.nih.gov/pubmed/31353053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2019.07.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak